Literature DB >> 15901133

Generalized herpes simplex virus infection in an immunocompromised patient--report of a case and review of the literature.

Georg Werner Herget1, Ursus Nikolaus Riede, Annette Schmitt-Gräff, Michael Lübbert, Dieter Neumann-Haefelin, Gabriele Köhler.   

Abstract

Patients with immunodeficiency or treatment-related immunosuppression are at an increased risk of developing severe herpes simplex virus (HSV) infection. We present a fatal case of a generalized HSV-1 infection in a 22-year-old female afflicted by acute lymphoblastic leukemia who was treated with polychemotherapy. The terminal clinical course was characterized by abdominal pain, progressive hepatic failure, and disseminated intravascular coagulation. Autopsy revealed non-perioral herpetic skin lesions and mucosal ulceration of the esophagus and colon. Punctuated areas of yellow-tan necrosis with hyperemic rims were detected in the liver, spleen, and lung. Numerous petechiae were observed on the mucosal surface of the esophagus, jejunum, ileum, and colon. Microscopically, lesions demonstrated the cellular changes characteristic of herpetic infection. Immunohistochemistry for identification of the virus using monoclonal antibodies against HSV-1 and HSV-2 showed positive staining for HSV-1. Polymerase chain reaction and sequencing confirmed HSV-1 positivity. Emphasis must be placed on clinical awareness of a generalized HSV infection in immunocompromised patients. Absence of orofacial or genital lesions does not rule out the possibility of active HSV infection.

Entities:  

Mesh:

Year:  2005        PMID: 15901133     DOI: 10.1016/j.prp.2004.12.003

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  16 in total

Review 1.  The Type I Interferon Response and Age-Dependent Susceptibility to Herpes Simplex Virus Infection.

Authors:  Daniel Giraldo; Douglas R Wilcox; Richard Longnecker
Journal:  DNA Cell Biol       Date:  2017-03-09       Impact factor: 3.311

2.  Apoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virus.

Authors:  Jin-Young Han; Derek D Sloan; Martine Aubert; Sara A Miller; Chung H Dang; Keith R Jerome
Journal:  Virology       Date:  2006-10-24       Impact factor: 3.616

3.  Extreme susceptibility of African naked mole rats (Heterocephalus glaber) to experimental infection with herpes simplex virus type 1.

Authors:  James Artwohl; Susan Ball-Kell; Tibor Valyi-Nagy; Steven P Wilson; Ying Lu; Thomas J Park
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

4.  Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient.

Authors:  Anne L Y Lecluse; Carla A F M Bruijnzeel-Koomen
Journal:  Case Rep Dermatol       Date:  2010-06-15

Review 5.  Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Authors:  Jairam R Lingappa; Connie Celum
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Cutaneous Conundrums in Cardiac Sarcoidosis: A Series on Skin Disease in Immunosuppression.

Authors:  Daisy Young; Sri Harsha Kanuri; Krishna Akella; Ghulam Murtaza; Rakesh Gopinathannair; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2020-08-31

7.  HIV-1 replication in HIV-infected individuals is significantly reduced when peripheral blood mononuclear cells are superinfected with HSV-1.

Authors:  Taneth Yamsuwan; Chintana Chirathaworn; Pokrath Hansasuta; Parvapan Bhattarakosol
Journal:  ScientificWorldJournal       Date:  2012-09-02

Review 8.  P-TEFb goes viral.

Authors:  Justyna Zaborowska; Nur F Isa; Shona Murphy
Journal:  Inside Cell       Date:  2015-11-25

Review 9.  Progress in Treatment of Viral Infections in Children with Acute Lymphoblastic Leukemia.

Authors:  Maria Moschovi; Maria Adamaki; Spiros A Vlahopoulos
Journal:  Oncol Rev       Date:  2016-06-30

Review 10.  Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.

Authors:  Aziz Alami Chentoufi; Lbachir Benmohamed
Journal:  Clin Dev Immunol       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.